Your browser doesn't support javascript.
loading
Synthesis, evaluation, and mechanism of 1-(4-(arylethylenylcarbonyl)phenyl)-4-carboxy-2-pyrrolidinones as potent reversible SARS-CoV-2 entry inhibitors.
Palla, Srinivasa Rao; Li, Chen-Wei; Chao, Tai-Ling; Lo, Hoi-Ling Vienn; Liu, Jia-Jin; Pan, Max Yu-Chen; Chiu, Yu-Ting; Lin, Wen-Chin; Hu, Chih-Wei; Yang, Chuen-Mi; Chen, Yi-Ying; Fang, Jun-Tung; Lin, Sheng-Wei; Lin, Yi-Tzu; Lin, Hsiao-Ching; Kuo, Chih-Jung; Wang, Lily Hui-Ching; Chang, Sui-Yuan; Liang, Po-Huang.
Afiliación
  • Palla SR; Institute of Biochemical Sciences, National Taiwan University, 10617, Taiwan; Taiwan International Graduate Program, Academia Sinica, Taipei 11529, Taiwan.
  • Li CW; Institute of Biochemical Sciences, National Taiwan University, 10617, Taiwan.
  • Chao TL; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, Taiwan.
  • Lo HV; Institute of Biochemical Sciences, National Taiwan University, 10617, Taiwan.
  • Liu JJ; Institute of Biochemical Sciences, National Taiwan University, 10617, Taiwan.
  • Pan MY; Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.
  • Chiu YT; Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.
  • Lin WC; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan; Graduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei 11490, Taiwan.
  • Hu CW; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan; Graduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei 11490, Taiwan; Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing Universit
  • Yang CM; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan.
  • Chen YY; Institute of Preventive Medicine, National Defense Medical Center, New Taipei City 23742, Taiwan; Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan.
  • Fang JT; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, Taiwan.
  • Lin SW; Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
  • Lin YT; Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
  • Lin HC; Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan; Institute of Biochemical Sciences, National Taiwan University, 10617, Taiwan; Taiwan International Graduate Program, Academia Sinica, Taipei 11529, Taiwan.
  • Kuo CJ; Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan. Electronic address: ck476@dragon.nchu.edu.tw.
  • Wang LH; Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan; School of Medicine, National Tsing Hua University, Hsinchu 30013, Taiwan. Electronic address: lilywang@life.nthu.edu.tw.
  • Chang SY; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan. Electronic address: sychang@ntu.edu.tw.
  • Liang PH; Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan; Institute of Biochemical Sciences, National Taiwan University, 10617, Taiwan; Taiwan International Graduate Program, Academia Sinica, Taipei 11529, Taiwan. Electronic address: phliang@gate.sinica.edu.tw.
Antiviral Res ; 219: 105735, 2023 11.
Article en En | MEDLINE | ID: mdl-37858764

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Antiviral Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Antiviral Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán